NCT01237678 2018-01-18
A Study of IMGN901 for Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer
ImmunoGen, Inc.
Phase 1/2 Terminated
Clinical Trials
5 trialsNCT00346385 2015-03-26
BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors
ImmunoGen, Inc.
Phase 1 Completed
NCT00991562 2014-11-21
IMGN901 in Combination With Lenalidomide and Dexamethasone
ImmunoGen, Inc.
Phase 1 Completed
NCT00346255 2013-04-23
IMGN901
ImmunoGen, Inc.
Phase 1 Completed
NCT00065429 2012-07-18
Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer
ImmunoGen, Inc.
Phase 1/2 Completed